Equities

Solasto Corp

Solasto Corp

Actions
Health CareHealth Care Providers
  • Price (JPY)473.00
  • Today's Change-3.00 / -0.63%
  • Shares traded36.90k
  • 1 Year change-19.42%
  • Beta1.1110
Data delayed at least 20 minutes, as of Nov 26 2024 00:40 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in JPYIncome statement in JPYView more

Year on year Solasto Corp had net income fall -28.87% from 3.17bn to 2.26bn despite a 3.09% increase in revenues from 131.09bn to 135.14bn. An increase in the cost of goods sold as a percentage of sales from 83.41% to 83.77% was a component in the falling net income despite rising revenues.
Gross margin16.41%
Net profit margin0.22%
Operating margin2.04%
Return on assets0.40%
Return on equity1.32%
Return on investment0.60%
More ▼

Cash flow in JPYView more

In 2024, Solasto Corp increased its cash reserves by 27.48%, or 3.26bn. The company earned 7.86bn from its operations for a Cash Flow Margin of 5.81%. In addition the company used 2.76bn on investing activities and also paid 1.84bn in financing cash flows.
Cash flow per share38.38
Price/Cash flow per share12.60
Book value per share233.33
Tangible book value per share62.22
More ▼

Balance sheet in JPYView more

Solasto Corp has a Debt to Total Capital ratio of 50.92%, a lower figure than the previous year's 73.16%.
Current ratio1.39
Quick ratio1.38
Total debt/total equity1.04
Total debt/total capital0.5092
More ▼

Growth rates in JPY

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -28.11%. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
Div yield(5 year avg)2.15%
Div growth rate (5 year)1.03%
Payout ratio (TTM)610.60%
EPS growth(5 years)-8.26
EPS (TTM) vs
TTM 1 year ago
-94.13
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.